MediWound (MDWD) Cash from Financing Activities (2016 - 2025)

MediWound has reported Cash from Financing Activities over the past 13 years, most recently at -$1.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 112.87% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached $29.6 million, up 52.73%, while the annual FY2025 figure was $29.6 million, 52.73% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$1.1 million at MediWound, down from $30.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $30.5 million in Q3 2025 and troughed at -$1.1 million in Q4 2025.
  • A 5-year average of $5.9 million and a median of -$174000.0 in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 808.0% in 2021 and later surged 8370.06% in 2022.
  • Year by year, Cash from Financing Activities stood at -$177000.0 in 2021, then surged by 8370.06% to $14.6 million in 2022, then plummeted by 101.39% to -$204000.0 in 2023, then tumbled by 151.47% to -$513000.0 in 2024, then crashed by 112.87% to -$1.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for MDWD at -$1.1 million in Q4 2025, $30.5 million in Q3 2025, and $549000.0 in Q2 2025.